Cullinan Oncology to Participate in the 41st Annual Canaccord Genuity Growth Conference

Rhea-AI Summary

Cullinan Oncology (Nasdaq: CGEM) will participate in the 41st Annual Canaccord Genuity Growth Conference from August 10 to August 12, 2021. The company’s Chief Financial Officer, Jeff Trigilio, will present on August 12 at 4:00 PM ET, accessible via the conference portal. Additionally, management will conduct one-on-one investor meetings during the event. Cullinan focuses on building a diversified pipeline of therapeutic candidates, emphasizing novel technologies and advanced development stages.

CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today that it will be participating in the 41^st Annual Canaccord Genuity Growth Conference from August 10^th to August 12^th, 2021.

Jeff Trigilio, Cullinan’s Chief Financial Officer, will be presenting on Thursday, August 12^th at 4:00pm ET. The presentation will be accessible through the Canaccord conference portal.

Event: Canaccord Genuity Growth Conference
Date: Thursday, August 12^th
Time: 4:00pm ET
Location: Virtual

Management will also be participating in one-on-one investor meetings throughout the conference. Investors interested in scheduling a meeting with Cullinan’s management should contact their Canaccord representative.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company that strives to deliver results for our various stakeholders through disciplined capital allocation, decisive action, prudent risk taking and creative business development. We seek to drive shareholder returns by focusing on the patient. The Company’s strategy is to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes. Learn more about Cullinan at www.cullinanoncology.com.

Contacts:

Investor Relations
investors@cullinanoncology.com

Jeff Trigilio
+1 617.410.4650
jtrigilio@cullinanoncology.com

FAQ

What is Cullinan Oncology's participation in the Canaccord Genuity Growth Conference?

Cullinan Oncology will participate in the 41st Annual Canaccord Genuity Growth Conference from August 10 to August 12, 2021.

When will Cullinan's CFO present at the Canaccord conference?

Jeff Trigilio, Cullinan's CFO, will present on August 12, 2021, at 4:00 PM ET.

How can investors meet Cullinan Oncology's management during the conference?

Investors interested in meetings with Cullinan's management can contact their Canaccord representative.

What is Cullinan Oncology's focus in its therapeutic pipeline?

Cullinan Oncology aims to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates with novel technologies and advanced development.

Where can I find more information about Cullinan Oncology?

More information about Cullinan Oncology can be found at www.cullinanoncology.com.